Loading…
Moolec Science SA is projected to decline to $6.86 by 2027, a -6% move from its current price of $7.33. MLEC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $7.03 | $7.32 | $7.63 | -0.11% |
| Jul 14 | $6.90 | $7.31 | $7.75 | -0.21% |
| Jul 15 | $6.81 | $7.31 | $7.84 | -0.32% |
| Jul 16 | $6.72 | $7.30 | $7.92 | -0.42% |
| Jul 17 | $6.65 | $7.29 | $7.99 | -0.53% |
| Jul 18 | $6.59 | $7.28 | $8.05 | -0.63% |
| Jul 19 | $6.53 | $7.28 | $8.11 | -0.74% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.53 | $7.28 | $8.11 | -0.74% |
| Week 2 | $6.20 | $7.22 | $8.42 | -1.47% |
| Week 3 | $5.94 | $7.17 | $8.65 | -2.20% |
| Week 4 | $5.73 | $7.12 | $8.84 | -2.92% |
| Week 5 | $5.54 | $7.06 | $9.00 | -3.63% |
| Week 6 | $5.38 | $7.01 | $9.15 | -4.34% |
| Week 7 | $5.22 | $6.96 | $9.27 | -5.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Moolec Science SA is a science-based ingredient company that develops ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in the Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Moolec Science SA operates in the healthcare category, delivering specialized ingredients and formulations across its diversified portfolio. Its focus is on leveraging biotechnological approaches to create novel food components and nutritional products that align with evolving dietary needs and industry demands.
Moolec Science SA (MLEC) is currently priced at $7.86 with a market cap of $5.71M and a rank of 5285. This places the stock among smaller-cap healthcare-focused offerings. The current price aligns with a year-by-year forecast that shows fluctuating but potential upside, with a 2026-average price of $7.86 and a broader multi-year path projecting higher values later in the decade and into 2050.
The forecast highlights a wide price range over the coming years: 2026 min $3.53, avg $7.86, max $8.96, with 2026 sentiment Neutral and ROI 0. By 2030 the average is projected at $11.06 (min $6.82, max $19.24) with a 40.7% ROI and a Bullish sentiment. By 2050 the average is $25.53 (min $11.49, max $58.73) with a 224.9% ROI and a Bullish sentiment, indicating substantial potential upside over the longer horizon.
These figures imply a mixed near-term path with more pronounced upside expected further out, subject to market dynamics and company-specific developments.
A major floor 19.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.8% below — buyers have tended to step in here.
The nearest ceiling, 11.6% above — a clean break opens room to run.
A major ceiling 56.1% above — clearing it would confirm fresh momentum.
Key MLEC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLEC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.56 | Sell | $7.51 | Sell |
| MA 10 | $7.67 | Sell | $7.61 | Sell |
| MA 20 | $7.71 | Sell | $7.67 | Sell |
| MA 50 | $8.02 | Sell | $7.85 | Sell |
| MA 100 | $8.79 | Sell | $8.95 | Sell |
| MA 200 | $8.38 | Sell | $19.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.34 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -135.34 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -8.38 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 42.58 | Neutral |
| Momentum (10) | -0.35 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 7.43 | Sell |
| ADX (14) | 6.34 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is Neutral. The RSI14 sits at 50, indicating a balanced momentum. The short-term moving averages show a level of potential resistance and support around the current price, with SMA50 at $8.13 and SMA200 at $9.31.
Immediate levels to watch are support at $6.83 and resistance at $10.45, framing a 30-day range that spans from $5.45 to $11.33. The asset exhibits high volatility, with annualized volatility listed at 100, underscoring the risk and potential for swift moves within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.53 | $7.33 | $8.67 | 0% | Neutral | |
| $5.21 | $6.86 | $9.70 | -6% | Neutral | |
| $5.13 | $7.07 | $10.52 | -4% | Neutral | |
| $5.88 | $8.41 | $13.03 | +15% | Neutral | |
| $6.28 | $9.28 | $14.87 | +27% | Bullish | |
| $6.01 | $9.16 | $15.11 | +25% | Bullish | |
| $5.61 | $8.80 | $14.90 | +20% | Bullish | |
| $4.81 | $7.76 | $13.43 | +6% | Neutral | |
| $5.00 | $8.27 | $14.63 | +13% | Neutral | |
| $5.88 | $9.98 | $18.00 | +36% | Bullish | |
| $6.15 | $11.79 | $23.05 | +61% | Bullish | |
| $10.45 | $23.21 | $50.93 | +217% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.53 | $7.33 | $8.98 | +0.00% |
| August 2026 | $5.99 | $7.17 | $8.88 | -2.25% |
| September 2026 | $5.50 | $6.66 | $8.38 | -7.10% |
| October 2026 | $5.47 | $6.68 | $8.52 | +0.30% |
| November 2026 | $5.60 | $6.89 | $8.90 | +3.25% |
| December 2026 | $5.36 | $6.65 | $8.67 | -3.56% |
Click any year to see its month-by-month MLEC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Moolec Science SA's 2026 outlook centres on $7.33, within a $3.53 to $8.67 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MLEC could reach as high as $9.70, with a base case around $6.86 and support toward $5.21 — roughly -6% from $7.33. A consolidation phase looks the most probable path here.
Expect MLEC to range from $5.13 to $10.52 through 2028. The $7.07 average target implies a -4% move from current prices. That is up +3% on the projected 2027 average. Price action looks broadly range-bound.
The MLEC price prediction for 2029 points to an average of $8.41 (low $5.88, high $13.03) — a potential gain of +15% on today's $7.33. A consolidation phase looks the most probable path here.
In 2030, MLEC is projected to trade between $6.28 and $14.87, averaging $9.28 — a potential gain of +27% from today's $7.33. That is up +10% on the projected 2029 average. Momentum favours further upside here.
Moolec Science SA's 2031 outlook centres on $9.16, within a $6.01 to $15.11 range. That is -1% versus the projected 2030 average. That marks a +25% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, MLEC could reach as high as $14.90, with a base case around $8.80 and support toward $5.61 — roughly +20% from $7.33. Momentum favours further upside here.
Expect MLEC to range from $4.81 to $13.43 through 2033. The $7.76 average target implies a +6% move from current prices. That is -12% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The MLEC price prediction for 2034 points to an average of $8.27 (low $5.00, high $14.63) — a potential gain of +13% on today's $7.33. Price action looks broadly range-bound.
In 2035, MLEC is projected to trade between $5.88 and $18.00, averaging $9.98 — a potential gain of +36% from today's $7.33. That is up +21% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Moolec Science SA's 2040 outlook centres on $11.79, within a $6.15 to $23.05 range. That is up +18% on the projected 2035 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2050, MLEC could reach as high as $50.93, with a base case around $23.21 and support toward $10.45 — roughly +217% from $7.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLEC today (≈ 136.423787 MLEC) could be worth
$3,166.71
+$2,166.71 (+217%) by 2050 · US Dollar
Based on the average projected MLEC price of $23.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLECwould be worth at today's price.
$1,000 invested in MLEC on Jul 10, 2025 (≈ 11.554015 MLEC) would be worth
$84.69
-$915.31 (-91.5%) today · 0.08× · US Dollar
Based on a MLEC entry price of $86.55 vs. today's $7.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.97 | $920.29 | -8.0% |
| 1 month ago | $7.25 | $1,011.05 | +1.1% |
| 3 months ago | $7.11 | $1,030.96 | +3.1% |
| 6 months ago | $4.11 | $1,783.48 | +78.3% |
| 1 year ago | $86.55 | $84.69 | -91.5% |
| All time (5.0y) ago | $1,468.5 | $4.99 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLEC forecast.
Our base-case forecast reaches $15.00 around 2050.
Implied market cap at $15.00: $10.89M
The multi-year forecast paints a bullish path toward the mid- and late-2020s and beyond, with notable milestones in 2030, 2031, 2035, 2040, and 2050. In 2030, the average is projected to $11.06 with a 40.7% ROI and a bullish sentiment, supported by a min of $6.82 and a max of $19.24. The 2031 reading shows an average of $9.84 with a 25.2% ROI, still within a bullish frame.
By 2035 the average climbs to $10.54 with a 34.2% ROI, and by 2040 the average reaches $11.69 with a 48.7% ROI, both reflecting ongoing bullish outlooks. The far horizon, 2050, shows a strong ascent to an average of $25.53 and a 224.9% ROI, with a max of $58.73 and a min of $11.49, indicating substantial long-term upside.
These numbers signal meaningful upside potential but remain estimates, not guarantees. The trajectory depends on factors such as market conditions, investor sentiment, and the company’s execution. Investors should treat these forecasts as directional guidance rather than certainties and consider the inherent uncertainty in long-horizon projections.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $11.06 with a min of $6.82 and a max of $19.24, and a ROI of 40.7%. The sentiment is bullish.
Forecasts indicate bullish sentiment in multiple future years (2030, 2031, 2035, 2040, 2050) with positive ROIs such as 40.7% in 2030, 25.2% in 2031, 34.2% in 2035, 48.7% in 2040, and 224.9% in 2050, but several years show neutral or smaller gains. These are estimates and not guarantees.
Yes. The 2050 forecast shows an average of $25.53, a max of $58.73, and a ROI of 224.9%, with bullish sentiment.
Current price is $7.86 and market cap is $5.71M.
The 30-day picture is Neutral, with RSI14 at 50, SMA50 at $8.13, SMA200 at $9.31, support at $6.83, resistance at $10.45, and a 30-day range from $5.45 to $11.33. Annualized volatility is 100.
Moolec Science SA Community Discussion
0Share your Moolec Science SA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.